Oxford Biomedica Balance Sheet Health
Financial Health criteria checks 4/6
Oxford Biomedica has a total shareholder equity of £198.2M and total debt of £38.4M, which brings its debt-to-equity ratio to 19.4%. Its total assets and total liabilities are £401.1M and £202.9M respectively.
Key information
19.4%
Debt to equity ratio
UK£38.44m
Debt
Interest coverage ratio | n/a |
Cash | UK£129.43m |
Equity | UK£198.16m |
Total liabilities | UK£202.91m |
Total assets | UK£401.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OXOA's short term assets (£177.7M) exceed its short term liabilities (£53.5M).
Long Term Liabilities: OXOA's short term assets (£177.7M) exceed its long term liabilities (£149.4M).
Debt to Equity History and Analysis
Debt Level: OXOA has more cash than its total debt.
Reducing Debt: OXOA's debt to equity ratio has reduced from 124.1% to 19.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if OXOA has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if OXOA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.